Methodist first to offer new drug-releasing artery stent locally
Methodist Le Bonheur is offering a new stent treatment for patients diagnosed with peripheral arterial disease, a condition that diabetics and those with high blood pressure are susceptible to develop.
Topics
Boston Scientific Methodist Le Bonheur Healthcare U.S. Food and Drug AdministrationMichelle Corbet
Michelle Corbet covers business for The Daily Memphian. Prior to, she was a reporter at the Memphis Business Journal. A native Memphian and University of Memphis graduate, Michelle covered business in Conway, Arkansas after college. Michelle got her start covering business as an intern at The Commercial Appeal.
Comments
Want to comment on our stories? If you’re a subscriber, scroll down to the comments. If you’re not a subscriber, only paid subscribers can add their thoughts, so subscribe now. Our commenting policy can be viewed here.